Delivery Order SPE2DB22D3010-SPE2DB25FP2BG
Award Date
3/31/25
Potential Completion Date
4/1/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $3,252.01 issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4,564,340 units of glimepiride 1 mg tablets. The contract has an ultimate completion date of April 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order valued at $1,170.74, is for the supply of Glimepiride 2 mg tablets in 100-count bottles. The award has an ultimate completion date of October 18, 2024 and is a Firm Fixed Price contract. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 4 mg glimepiride tablets to the Defense Logistics Agency (DLA) under a firm-fixed price Delivery Order. The contract has a ceiling value of $2,300.67 and an ultimate completion date of March 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,073.81, is a Delivery Order for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,273.93 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,478,133 tablets of the medication Glimepiride 4 mg and has a period of performance through May 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999.00 through December 31, 2025,...
This federal contract award, valued at $2,284.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,058,247 units of the medication Glimepiride 4 mg tablets in 100-count bottles. The contract has a firm fixed price and an ultimate completion date of April 29, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,399.32 Firm Fixed Price delivery order is for the supply of 4,559,465,173 units of 4 mg Glimepiride tablets. The award was made on December 28, 2022, with a period of performance through December 29, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, held by...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,322.54 Firm Fixed Price Delivery Order is for the provision of 4,564,326,421 tablets of the pharmaceutical drug Glimepiride 4 mg. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB24D2011|SPE2DB24FBQPM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,197.58 firm fixed-price delivery order is for the supply of 4565239883 Glimepiride 4 mg tablets. The contract has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Glimepiride 4 mg tablets. The $1,872.20 contract has a performance period through March 12, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...